Historical Stock Price
MGNX historical stock prices picture
MacroGenics (MGNX) has the following price history information. Looking back at MGNX historical stock prices for the last five trading days, on April 12, 2024, MGNX opened at $18.38, traded as high as $18.54 and as low as $17.12, and closed at $17.54. Trading volume was a total of 875.20K shares. On April 15, 2024, MGNX opened at $17.48, traded as high as $17.72 and as low as $16.67, and closed at $16.94. Trading volume was a total of 820.50K shares. On April 16, 2024, MGNX opened at $16.86, traded as high as $17.24 and as low as $16.62, and closed at $16.68. Trading volume was a total of 628.30K shares. On April 17, 2024, MGNX opened at $16.74, traded as high as $16.83 and as low as $16.00, and closed at $16.10. Trading volume was a total of 953.00K shares. On April 18, 2024, MGNX opened at $15.99, traded as high as $16.38 and as low as $15.82, and closed at $16.07. Trading volume was a total of 660.30K shares.

MGNX Historical Stock Prices By Date:

MGNX historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into MacroGenics shares, starting with a $10,000 purchase of MGNX, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/22/2014
End date: 04/18/2024
Start price/share: $19.21
End price/share: $16.07
Dividends collected/share: $0.00
Total return: -16.35%
Average Annual Total Return: -1.77%
Starting investment: $10,000.00
Ending investment: $8,364.94
Years: 10.00
Date Open High Low Close Volume
04/12/2024 $18.38 $18.54 $17.12 $17.54 875.20K
04/15/2024 $17.48 $17.72 $16.67 $16.94 820.50K
04/16/2024 $16.86 $17.24 $16.62 $16.68 628.30K
04/17/2024 $16.74 $16.83 $16.00 $16.10 953.00K
04/18/2024 $15.99 $16.38 $15.82 $16.07 660.30K
MacroGenics is a biopharmaceutical company. Co.'s main pipeline program is vobramitamab duocarmazine, an antibody-drug conjugate that targets B7-H3, a molecule in the B7 family of immune regulator proteins that is expressed by several different tumor types. Co. is also developing molecules that target programmed cell death protein 1 (PD-1), a protein that is important in the regulation of the immune system's response to cancer. In addition, Co. is developing MGD024, a bispecific DART molecule that engages CD3 on immune effector cells to kill CD123-expressing cancer cells in certain hematological malignancies, including acute myeloid leukemia.
Date Close
04/12/2024$17.54
04/15/2024$16.94
04/16/2024$16.68
04/17/2024$16.10
04/18/2024$16.07
MGNX is categorized under the Healthcare sector; below are some other companies in the same sector:

MICR Historical Stock Prices
MIR Historical Stock Prices
MIRN Historical Stock Prices
MLNT Historical Stock Prices
MLSS Historical Stock Prices
MMM Historical Stock Prices
MMSI Historical Stock Prices
MNKD Historical Stock Prices
MNOV Historical Stock Prices
MNTA Historical Stock Prices

Also explore: MGNX shares outstanding history

Email EnvelopeFree MGNX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


MGNX Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.